Cancer Research UK logo.
SearchDonate
  • Search

A study to see if bortezomib and an epilepsy drug could be a treatment for melanoma or bowel cancer

Overview

Cancer types:

Bowel (colorectal) cancer, Melanoma, Skin cancer

Status:

Results

Phase:

Phase 2

Details

This study was to find out how small doses of bortezomib (Velcade) and the epilepsy drug sodium valproate worked in people with melanoma or bowel cancer.

Recruitment start: 21 August 2009

Recruitment end: 9 December 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof Mark Middleton

Supported by

Experimental Cancer Medicine Centre (ECMC)

Oxford Cancer Research Centre

Oxford Radcliffe Hospitals NHS Trust

Last reviewed: 28 Apr 2014

CRUK internal database number: 4453

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.